540 related articles for article (PubMed ID: 29578532)
21. Helios
Thornton AM; Lu J; Korty PE; Kim YC; Martens C; Sun PD; Shevach EM
Eur J Immunol; 2019 Mar; 49(3):398-412. PubMed ID: 30620397
[TBL] [Abstract][Full Text] [Related]
22. Recent thymic emigrants are the preferential precursors of regulatory T cells differentiated in the periphery.
Paiva RS; Lino AC; Bergman ML; Caramalho I; Sousa AE; Zelenay S; Demengeot J
Proc Natl Acad Sci U S A; 2013 Apr; 110(16):6494-9. PubMed ID: 23576744
[TBL] [Abstract][Full Text] [Related]
23. GPA33: A Marker to Identify Stable Human Regulatory T Cells.
Opstelten R; de Kivit S; Slot MC; van den Biggelaar M; Iwaszkiewicz-Grześ D; Gliwiński M; Scott AM; Blom B; Trzonkowski P; Borst J; Cuadrado E; Amsen D
J Immunol; 2020 Jun; 204(12):3139-3148. PubMed ID: 32366581
[TBL] [Abstract][Full Text] [Related]
24. Role of Cytokines in Thymic Regulatory T Cell Generation: Overview and Updates.
Tang M; Jia F; Nan F; Zuo F; Yuan Z; Zhang D
Front Immunol; 2022; 13():883560. PubMed ID: 35432378
[TBL] [Abstract][Full Text] [Related]
25. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.
Takeda I; Ine S; Killeen N; Ndhlovu LC; Murata K; Satomi S; Sugamura K; Ishii N
J Immunol; 2004 Mar; 172(6):3580-9. PubMed ID: 15004159
[TBL] [Abstract][Full Text] [Related]
26. OX40/OX40L costimulation affects induction of Foxp3+ regulatory T cells in part by expanding memory T cells in vivo.
Xiao X; Kroemer A; Gao W; Ishii N; Demirci G; Li XC
J Immunol; 2008 Sep; 181(5):3193-201. PubMed ID: 18713990
[TBL] [Abstract][Full Text] [Related]
27. OX40, OX40L and Autoimmunity: a Comprehensive Review.
Webb GJ; Hirschfield GM; Lane PJ
Clin Rev Allergy Immunol; 2016 Jun; 50(3):312-32. PubMed ID: 26215166
[TBL] [Abstract][Full Text] [Related]
28. OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.
Kitamura N; Murata S; Ueki T; Mekata E; Reilly RT; Jaffee EM; Tani T
Int J Cancer; 2009 Aug; 125(3):630-8. PubMed ID: 19455675
[TBL] [Abstract][Full Text] [Related]
29. A two-step process for thymic regulatory T cell development.
Lio CW; Hsieh CS
Immunity; 2008 Jan; 28(1):100-11. PubMed ID: 18199417
[TBL] [Abstract][Full Text] [Related]
30. Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment.
Bresson D; Fousteri G; Manenkova Y; Croft M; von Herrath M
J Autoimmun; 2011 Dec; 37(4):342-51. PubMed ID: 22063316
[TBL] [Abstract][Full Text] [Related]
31. Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells.
Mahmud SA; Manlove LS; Schmitz HM; Xing Y; Wang Y; Owen DL; Schenkel JM; Boomer JS; Green JM; Yagita H; Chi H; Hogquist KA; Farrar MA
Nat Immunol; 2014 May; 15(5):473-81. PubMed ID: 24633226
[TBL] [Abstract][Full Text] [Related]
32. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
33. Thymic origins of autoimmunity-lessons from inborn errors of immunity.
Bacchetta R; Weinberg K
Semin Immunopathol; 2021 Feb; 43(1):65-83. PubMed ID: 33532929
[TBL] [Abstract][Full Text] [Related]
34. Single-Cell Transcriptomics Reveals Discrete Steps in Regulatory T Cell Development in the Human Thymus.
Morgana F; Opstelten R; Slot MC; Scott AM; van Lier RAW; Blom B; Mahfouz A; Amsen D
J Immunol; 2022 Jan; 208(2):384-395. PubMed ID: 34937744
[TBL] [Abstract][Full Text] [Related]
35. CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion.
St Rose MC; Taylor RA; Bandyopadhyay S; Qui HZ; Hagymasi AT; Vella AT; Adler AJ
Immunol Cell Biol; 2013 Feb; 91(2):173-83. PubMed ID: 23295363
[TBL] [Abstract][Full Text] [Related]
36. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation.
Piconese S; Gri G; Tripodo C; Musio S; Gorzanelli A; Frossi B; Pedotti R; Pucillo CE; Colombo MP
Blood; 2009 Sep; 114(13):2639-48. PubMed ID: 19643985
[TBL] [Abstract][Full Text] [Related]
37. Analysis of miR-146a and miR-142-3p as Potential Markers of Freshly Isolated or In Vitro-Expanded Human Treg cells.
Holmstrøm K; Pedersen AE; Gad M
Scand J Immunol; 2017 Feb; 85(2):113-121. PubMed ID: 27943367
[TBL] [Abstract][Full Text] [Related]
38. ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection.
Metzger TC; Long H; Potluri S; Pertel T; Bailey-Bucktrout SL; Lin JC; Fu T; Sharma P; Allison JP; Feldman RM
Cancer Res; 2016 Jul; 76(13):3684-9. PubMed ID: 27197182
[TBL] [Abstract][Full Text] [Related]
39. New insights on OX40 in the control of T cell immunity and immune tolerance in vivo.
Xiao X; Gong W; Demirci G; Liu W; Spoerl S; Chu X; Bishop DK; Turka LA; Li XC
J Immunol; 2012 Jan; 188(2):892-901. PubMed ID: 22147766
[TBL] [Abstract][Full Text] [Related]
40. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
Kim YC; Zhang AH; Yoon J; Culp WE; Lees JR; Wucherpfennig KW; Scott DW
J Autoimmun; 2018 Aug; 92():77-86. PubMed ID: 29857928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
